The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Central Nervous System Side Effects Associated with Zolpidem Treatment
Abstract
Zolpidem is one of the newer medications developed for the treatment of insomnia. It is an imidazopyridine agent that is an alternative to the typical sedative-hypnotic agents. Zolpidem use is gaining favor because of its efficacy and its side effect profile, which is milder and less problematic than that of the benzodiazepines and barbiturates used to treat insomnia. Still, side effects are not uncommon with zolpidem use. We report a series of cases in which the patients developed delirium, nightmares and hallucinations during treatment with zolpidem. We will review its pharmacology, discuss previous reports of central nervous system side effects, examine the impact of drug interactions with concurrent use of antidepressants, examine gender differences in susceptibility to side effects, and explore the significance of protein binding in producing side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zolpidem: A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Potential
Langtry, H. D., & Benfield, P. (1990) · Drugs · doi:10.2165/00003495-199040020-00008 · Cited by 297
Pharmacokinetics of antidepressants: why and how they are relevant to treatment.
Cummings, J. L. (1993) · PubMed · Cited by 262
Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability.
Evans, S. M., Funderburk, F. R., & Griffiths, R. R. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23193-7 · Cited by 165
Drug interactions with newer antidepressants: role of human cytochromes P450.
Greenblatt, D. J., Moltke, L. L., Harmatz, J. S., & Shader, R. I. (1998) · PubMed · Cited by 141
Richelson, E. (1997) · Mayo Clinic Proceedings · doi:10.4065/72.9.835 · Cited by 130
Markowitz, J. S., & Brewerton, T. D. (1996) · Annals of Clinical Psychiatry · doi:10.3109/10401239609148806 · Cited by 93
Roger, M., Attali, P., & Jp, C. (1993) · PubMed · Cited by 85
Zolpidem-Associated Hallucinations and Serotonin Reuptake Inhibition: A Possible Interaction
Elko, C. J., Burgess, J. L., & Robertson, W. O. (1998) · Journal of Toxicology Clinical Toxicology · doi:10.3109/15563659809028939 · Cited by 84
Psychotic reactions to zolpidem
Ansseau, M., Pitchot, W., Hansenne, M., & Moreno, A. G. (1992) · The Lancet · doi:10.1016/0140-6736(92)91935-2 · Cited by 76
Clonidine treatment of excessive sweating.
Feder, R. (1995) · PubMed · Cited by 69
Cited by
Zolpidem: A Review of Its Use in the Management of Insomnia
Swainston Harrison, T., & Keating, G. M. (2005) · CNS Drugs · doi:10.2165/00023210-200519010-00008 · Cited by 323
Amnestic sleep-related eating disorder associated with zolpidem
Morgenthaler, T. I., & Silber, M. H. (2002) · Sleep Medicine · doi:10.1016/s1389-9457(02)00007-2 · Cited by 185
In Search of a Safe Natural Sleep Aid
Rao, T. P., Ozeki, M., & Juneja, L. R. (2015) · Journal of the American College of Nutrition · doi:10.1080/07315724.2014.926153 · Cited by 59
New-Onset Transilent Hallucinations Possibly Due To Eszopiclone: A Case Study
Duggal, H. S. (2007) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v09n0611e · Cited by 10
Chate, S., Nayak, R., Patil, N., & Chattopadhyay, S. (2013) · Journal of the Scientific Society · doi:10.4103/0974-5009.120050 · Cited by 2
Metadata
- Authors
- Toner, L. C., Tsambiras, B. M., Catalano, G., Catalano, M. C., & Cooper, D. S.
- Venue
- Clinical Neuropharmacology
- Published
- 2000-01
- Volume
- 23
- Issue
- 1
- Pages
- 54-58
- ISSN
- 0362-5664 (ISSN-L)
- OpenAlex
- W2057132224
- Cited by
- 273
- References
- 17
- FWCI
- 4.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Central Nervous System Side Effects Associated with Zolpidem Treatment. https://app.cochat.ai/papers/10.1097/00002826-200001000-00011
- The paper
- Toner, L. C., Tsambiras, B. M., Catalano, G., Catalano, M. C., & Cooper, D. S. (2000). Central Nervous System Side Effects Associated with Zolpidem Treatment. Clinical Neuropharmacology. https://doi.org/10.1097/00002826-200001000-00011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.